Targeted Strategies for Today's Evolving Markets

MissionIR Blog

MissionIRNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Offers ‘Radical Price Transparency’ to Maximize Savings, Lower Costs of Pharmaceuticals

Trxade Group (NASDAQ: MEDS), an integrated drug-procurement, delivery and health-care platform, has achieved a growing distinction and web-based presence, offering transparency in pharmaceutical purchasing. The company’s flagship Bonum+ platform provides subscribers with access to drug prices and supply availability, enabling them to make informed product ordering decisions. A recent article discussing this quotes Trxade Group founder, chairman and CEO Suren Ajjarapu, who states, “Our platform lets these independents know that they’re receiving a fair price from competing suppliers on fair payment terms and often with next day delivery. We believe this radical price transparency, economy of scale and competition amongst suppliers leads to up to a 10% reduction in pharmacies’ total annual drug purchase costs, with a drug-level savings of up to 90% on certain pharmaceutical products.”

To view the full article, visit http://ibn.fm/HGSJn

About Trxade Group Inc.

Headquartered in Tampa, Florida, Trxade Group is an integrated drug-procurement, delivery and health-care platform that fosters price transparency, thereby improving profit margins for both buyers and sellers of pharmaceuticals. Trxade Group operates across all 50 states with the central mission of making health-care services affordable and accessible. Founded in 2010, Trxade Group is comprised of four synergistic operating platforms: (1) the Trxade B2B trading platform with 11,725 registered pharmacies; (2) Integra Pharma Solutions, Trxade Group’s virtual wholesale division; (3) the Bonum Health platform offering affordable telehealth services; and (4) the DelivMeds app, which coordinates a nationwide distribution network through independent pharmacies or mail-order delivery. For additional information, please visit www.Trxade.com, www.DelivMeds.com and www.BonumHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

This entry was posted in Trxade Group Inc. (MEDS). Bookmark the permalink.

Comments are closed.